QURE(uniQure N.V.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $524.00M | $106.48M | $15.84M | $27.12M | $16.10M |
| 毛利润 | $499.03M | $105.23M | $15.78M | $25.85M | $14.41M |
| 营业利润 | $310.62M | −$143.16M | −$282.87M | −$184.29M | −$185.35M |
| 净利润 | $329.59M | −$126.79M | −$308.48M | −$239.56M | −$198.97M |
| 经营现金流 | $287.96M | −$145.06M | −$145.93M | −$182.73M | −$177.96M |
| 自由现金流 | $270.52M | −$162.75M | −$153.08M | −$186.10M | −$178.40M |
| 摊薄每股收益 | $7.04 | $-2.71 | $-6.47 | $-4.92 | $-3.46 |